{"metadata": {"source": "erowid", "title": "Erowid Amphetamine (Adderall) Vault", "description": "Information about Amphetamines (speed) including basics, effects, dosage, history, legal status, photos, research, media coverage, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/amphetamines/amphetamines.shtml", "drug": "Amphetamine", "cid": 3007, "substance": "amphetamines", "category": "CHEMICALS", "erowid_column": "MainPage", "char_count": 7699, "word_count": 1111, "doc_id": "doc_116", "num_chunks": 10, "chunk_id": "116::chunk_9", "document_index": 116, "latency_s": 1.0046751000045333, "prompt_toks": 2328, "completion_toks": 85, "relevance_score": 0.0006411777}, "content": "Drug: Amphetamine | cid: 3007\nSource: erowid | Source description: Information about Amphetamines (speed) including basics, effects, dosage, history, legal status, photos, research, media coverage, and links to other resources.\nErowid name: amphetamines\nCategory: CHEMICALS\nField: MainPage\n\n                    Text: \n                    Is Ritalin Raising Kids To Be Drug Addicts? - EagleForum, 2000\n\nHEALTH #\n\nDo ADHD Drugs Take a Toll on the Brain? - Jul 2009, Scientific American\n\nSTATISTICS #\n\nRitalin and Amphetamine Use Increase, Frontline PBS\n\nPROHIBITION SITES #\n\nAmphetamines - DEA\n\nMentalHealth.com : Amphetamine Dependence\n\nDEA : Methamphetamine & Amphetamines\n\n[ back to chemicals ]\n\nCreated by Erowid - 1997 Modified - Sep 7, 2020\n\nContent & design © 1995-2023 Erowid.org. Permission required before publicly reproducing Erowid info.\n\n\n                    Context: \n                    This chunk covers concerns about the impact of ADHD medications like Ritalin on children, citing an article from EagleForum (2000), alongside health-related questions about the effects of ADHD drugs on the brain, recent statistics on Ritalin and amphetamine use from Frontline PBS, and related prohibition resources from DEA and MentalHealth.com. It is relevant to the document’s focus on substances, health implications, and drug policy.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_17", "document_index": 84, "latency_s": 0.5436048999981722, "prompt_toks": 6387, "completion_toks": 45, "relevance_score": 0.0006337125}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    References\n\n↑ Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., Guimarães, F. S. (5 December 2012). \"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders\". Philosophical Transactions of the Royal Society B: Biological Sciences. 367 (1607): 3364–3378. doi:10.1098/rstb.2011.0389. ISSN 0962-8436.\n\n↑ \"Epidiolex (Cannabidiol) FDA Label\" (PDF). fda.gov. Retrieved 28 June 2018. For label updates see FDA index page for NDA 210365\n\n↑ 3.0 3.1 FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy, 2018, retrieved 25 June 2018\n\n↑ LaVito, A., DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market\n\n↑ Angell, T. (2018), UN Launches First-Ever Full Review Of Marijuana’s Status Under International Law\n\n\n                    Context: \n                    This references section lists key scientific studies and official sources related to cannabidiol's mechanisms, medical approvals, and legal status, providing foundational evidence supporting the informational content of the full document on cannabidiol (CBD).\n                "}
{"metadata": {"source": "erowid", "title": "Erowid LSD (Acid) Vault : FAQ", "description": "Frequently Asked Questions about LSD", "language": "No language found.", "url": "https://www.erowid.org/chemicals/lsd/lsd_faq.shtml", "drug": "LSD", "cid": 5761, "substance": "lsd", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 70642, "word_count": 10952, "doc_id": "doc_156", "num_chunks": 103, "chunk_id": "156::chunk_51", "document_index": 156, "latency_s": 1.3747832000080962, "prompt_toks": 16347, "completion_toks": 76, "relevance_score": 0.00055494095}, "content": "Drug: LSD | cid: 5761\nSource: erowid | Source description: Frequently Asked Questions about LSD\nErowid name: lsd\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    Can smoking marijuana induce a flashback? Also are you more likely to suffer flashbacks from having a bad trip? Apparently yes and yes. The following is reproduced without permission from Lester Grinspoon and James B. Bakalar, \"Psychedelic Drugs Reconsidered,\" Basic Books, Inc. New York, 1979. pp. 159-163. I highly recommend this book, and if you find it please buy me one too. I typed this in a while ago and didn't type in the references at the time (slap!). If you want them i'll see what i can do. Typos are mine.\n\n\n                    Context: \n                    This excerpt addresses the phenomenon of flashbacks related to psychedelic drugs, specifically discussing whether marijuana use or a negative trip increases their likelihood. It provides insights from Lester Grinspoon and James Bakalar's \"Psychedelic Drugs Reconsidered,\" emphasizing the psychological nature of flashbacks and individual susceptibility, which is relevant to the overall exploration of psychedelic risks and effects in the full webpage.\n                "}
